Menu
  • Join
  • Login
  • Contact
 

Search abstracts


PLASMA DISPOSITION OF PROCHLORPERAZINE AND GENDER AFFECT ITS ANTIEMETIC EFFECT AND PROLACTIN SECRETION IN CANCER PAIN PATIENTS TREATED WITH OXYCODONE

  • At: 2015 FIP Congress in Düsseldorf (Germany)
  • Type: Poster
  • By: TASHIRO, Masaki (Hamamatsu University Hospital, Hospital Pharmacy, Hamamatsu, Japan)
  • Co-author(s): Masaki Tashiro
  • Abstract:

    Prochlorperazine (PCPZ), a dopamine receptor D2 antagonist, is used for the antiemetic treatment of opioid-induced nausea and vomiting. Few clinical reports have been published on the interindividual variations in the clinical responses to PCPZ in opioid analgesics treated cancer patients.

    Sixty-one cancer pain patients receiving PCPZ concomitantly

    ..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses